U.S., Jan. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07324161) titled 'Efficacy and Safety of Transcranial Magnetic Stimulation in Treatment of Alzheimer's Disease' on Dec. 24, 2025.
Brief Summary: This study is grounded in the regulatory mechanisms of the glymphatic system and applies repetitive transcranial magnetic stimulation (rTMS) to the treatment of Alzheimer's disease (AD). The clinical efficacy and safety of rTMS will be systematically evaluated. Furthermore, transcranial magnetic stimulation-evoked potentials (TMS-EEG) and functional near-infrared spectroscopy (fNIRS) will be employed to investigate, from the perspectives of synaptic plasticity and neurovascular coupling, the mechanisms by whi...